Retrospective research for efficacy and safety of modified FOLFIRINOX as 1st line therapy for advanced pancreatic cancer

被引：0
|
作者：
Dazai, Masayoshi [1 ,2 ]
Suzuki, Kazuharu [1 ]
Nakajima, Masahito [1 ]
Yagisawa, Masataka [1 ]
Kobayashi, Yoshimitu [1 ]
Kudo, Taiki [1 ]
Takahashi, Kazuhiro [1 ]
Sogabe, Susumu [1 ]
Oda, Hisashi [1 ]
Miyagishima, Takuto [1 ]
机构：
[1] Kushiro Rosai Hosp, Dept Internal Med, Kushiro, Hokkaido, Japan
[2] NTT East Sapporo Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-8-9
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [21] Retrospective single center review of toxicity and efficacy of a modified FOLFIRINOX regimen in patients with locally advanced and metastatic pancreatic cancer.
    Pulluri, Bhargavi
    Skelly, Joan
    Barry, Maura Meredith
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [22] FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
    Krishna S. Gunturu
    Xiaopan Yao
    Xiangyu Cong
    Jaykumar R. Thumar
    Howard S. Hochster
    Stacey M. Stein
    Jill Lacy
    Medical Oncology, 2013, 30
  • [23] Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer
    Chikhareva, Y.
    Fedyanin, M.
    Bazin, I.
    Pokataev, I.
    Manukyan, M.
    Kantieva, D.
    Tryakin, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S131 - S131
  • [24] The role of modified FOLFIRINOX regimen in unresectable advanced pancreatic cancer: A retrospective clinical study.
    Qian, Yuan
    Zheng, Song
    Jia, Changku
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
    Gunturu, Krishna S.
    Yao, Xiaopan
    Cong, Xiangyu
    Thumar, Jaykumar R.
    Hochster, Howard S.
    Stein, Stacey M.
    Lacy, Jill
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [26] Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
    Mahaseth, Hemchandra
    Brutcher, Edith
    Kauh, John
    Hawk, Natalyn
    Kim, Sungin
    Chen, Zhengjia
    Kooby, David A.
    Maithel, Shishir K.
    Landry, Jerome
    El-Rayes, Bassel F.
    PANCREAS, 2013, 42 (08) : 1311 - 1315
  • [27] Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience.
    Lakatos, G.
    Petranyi, A.
    Szucs, A.
    Nehez, L.
    Harsanyi, L.
    Hegyi, P.
    Bodoky, G.
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (04) : 753 - 759
  • [28] Efficacy and safety of FOLFIRINOX in elderly patients with advanced pancreatic adenocarcinoma.
    Jung, Jae Hyup
    Kang, Jingu
    Lee, Jong-Chan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] HCG experience of modified FOLFIRINOX regimen in advanced pancreatic cancer
    Satheesh, Thungappa
    Shashidhara, P.
    Ravi, Thippeswamy
    Shekar, Patil
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-analysis
    Lu, Wenjie
    Wang, Lantian
    Li, Xiawei
    Tang, Kezhong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (04)
12345